Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.250 $0.685 Friday, 10th May 2024 ADXS stock ended at $0.437. This is 21.96% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 108.00% from a day low at $0.250 to a day high of $0.520.
90 days $0.250 $1.05
52 weeks $0.250 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Oct 21, 2016 $137.10 $137.10 $137.10 $137.10 42 840
Oct 20, 2016 $138.15 $138.15 $138.15 $138.15 40 080
Oct 19, 2016 $132.15 $132.15 $132.15 $132.15 35 680
Oct 18, 2016 $134.40 $134.40 $134.40 $134.40 42 980
Oct 17, 2016 $134.85 $134.85 $134.85 $134.85 60 267
Oct 14, 2016 $133.20 $133.20 $133.20 $133.20 76 887
Oct 13, 2016 $141.00 $141.00 $141.00 $141.00 101 727
Oct 12, 2016 $146.85 $146.85 $146.85 $146.85 69 133
Oct 11, 2016 $154.05 $154.05 $154.05 $154.05 62 747
Oct 10, 2016 $167.55 $167.55 $167.55 $167.55 32 127
Oct 07, 2016 $160.80 $160.80 $160.80 $160.80 52 067
Oct 06, 2016 $165.60 $165.60 $165.60 $165.60 53 760
Oct 05, 2016 $178.50 $178.50 $178.50 $178.50 79 033
Oct 04, 2016 $180.90 $180.90 $180.90 $180.90 110 593
Oct 03, 2016 $164.40 $164.40 $164.40 $164.40 28 333
Sep 30, 2016 $160.35 $160.35 $160.35 $160.35 42 120
Sep 29, 2016 $155.85 $155.85 $155.85 $155.85 45 313
Sep 28, 2016 $163.65 $163.65 $163.65 $163.65 42 193
Sep 27, 2016 $162.15 $162.15 $162.15 $162.15 35 107
Sep 26, 2016 $158.10 $158.10 $158.10 $158.10 49 173
Sep 23, 2016 $162.00 $162.00 $162.00 $162.00 40 860
Sep 22, 2016 $164.70 $164.70 $164.70 $164.70 49 087
Sep 21, 2016 $164.55 $164.55 $164.55 $164.55 50 913
Sep 20, 2016 $158.40 $158.40 $158.40 $158.40 38 273
Sep 19, 2016 $156.15 $156.15 $156.15 $156.15 61 440
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT